Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex

Approvals Action
One prescription drug added

Posted 22 December 2020 

Seqirus was the sole sponsor to register a prescription drug on the ARTG over the last week with the TGA ticking its eye drop treatment for patients with dry eyes.

The registration of Ikervis makes Seqirus the second company to register active ingredient ciclosporin for the indication following Sun Pharma's entry of Cequa earlier this year.

Novartis also has products containing ciclosporin that are used as an immunosuppressive agent following transplantation and inflammatory diseases. Neoral and Sandimmun are PBS listed.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
Timely support for meds regulator
Threats and harassment may warrant extra TGA powers
Approvals Action
Four new therapies ticked
Plus, the disputed first generic of MSD?s diabetes drug